In our analysis three times more PSMA SPECT/CT could be analyzed; therefore, relevant data could be evaluated on the integration of PSMA SPECT/CT in the definition of SBRT target volume of low-volume progressing prostate cancer. This evidence concerns the gene FOLH1 and Familial prostate cancer.